{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:49:09Z","timestamp":1786708149880,"version":"build-2736575974"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11996-y","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:46:45Z","timestamp":1763038005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of potentially inappropriate medications in people living with HIV: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Mustapha Muhammed","family":"Abubakar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmuminu","family":"Isah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Jeminiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibraheem","family":"Abioye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismaeel","family":"Yunusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Abba-Aji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osagie Kenneth","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamila","family":"Sani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukhtar","family":"Ijaiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwuemeka","family":"Nwachuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Usman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duke","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwaseun Samuel","family":"Ilugbuhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blessing Onyinye","family":"Ukoha-Kalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"11996_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/nejmp1916753","volume":"383","author":"AS Fauci","year":"2020","unstructured":"Fauci AS, Lane HC. Four decades of HIV\/AIDS \u2014 much Accomplished, much to do. N Engl J Med. 2020;383:1\u20134. https:\/\/doi.org\/10.1056\/nejmp1916753.","journal-title":"N Engl J Med"},{"key":"11996_CR2","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1016\/S2352-3018(23)00028-0","volume":"10","author":"A Trickey","year":"2023","unstructured":"Trickey A, Sabin CA, Burkholder G, Crane H, d\u2019Arminio Monforte A, Egger M, et al. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North america: a collaborative analysis of cohort studies. Lancet HIV. 2023;10:e295\u2013307. https:\/\/doi.org\/10.1016\/S2352-3018(23)00028-0.","journal-title":"Lancet HIV"},{"key":"11996_CR3","unstructured":"Joint United Nations Programme on HIV\/AIDS. The Path that ends AIDS 2023 Unaids global AIDS update. 2023."},{"key":"11996_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S1473-3099(15)00056-0","volume":"15","author":"M Smit","year":"2015","unstructured":"Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, van Sighem AV, et al. Future challenges for clinical care of an ageing population infected with HIV: A modelling study. Lancet Infect Dis. 2015;15:810\u20138. https:\/\/doi.org\/10.1016\/S1473-3099(15)00056-0.","journal-title":"Lancet Infect Dis"},{"key":"11996_CR5","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1183\/09031936.00059814","volume":"44","author":"MJ Divo","year":"2014","unstructured":"Divo MJ, Martinez CH, Mannino DM. Ageing and the epidemiology of Multimorbidity. Eur Respir J. 2014;44:1055\u201368. https:\/\/doi.org\/10.1183\/09031936.00059814.","journal-title":"Eur Respir J"},{"key":"11996_CR6","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","volume":"138","author":"ASV Shah","year":"2018","unstructured":"Shah ASV, Stelzle D, Ken Lee K, Beck EJ, Alam S, Clifford S, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV systematic review and meta-analysis. Circulation. 2018;138:1100\u201312. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.033369.","journal-title":"Circulation"},{"key":"11996_CR7","doi-asserted-by":"publisher","unstructured":"Pourcher V, Gourmelen J, Bureau I, Bouee S. Comorbidities in people living with HIV: an epidemiologic and economic analysis using a claims database in France. PLoS ONE. 2020;15. https:\/\/doi.org\/10.1371\/journal.pone.0243529.","DOI":"10.1371\/journal.pone.0243529"},{"key":"11996_CR8","doi-asserted-by":"publisher","unstructured":"Roomaney RA, van Wyk B, Wyk VP, Van. Aging with HIV: increased risk of HIV comorbidities in older adults. Int J Environ Res Public Health 2022;19. https:\/\/doi.org\/10.3390\/ijerph19042359.","DOI":"10.3390\/ijerph19042359"},{"key":"11996_CR9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2147\/CIA.S37738","volume":"8","author":"LJ Gleason","year":"2013","unstructured":"Gleason LJ, Luque AE, Shah K. Polypharmacy in the HIV-infected older adult population. Clin Interv Aging. 2013;8:749\u201363. https:\/\/doi.org\/10.2147\/CIA.S37738.","journal-title":"Clin Interv Aging"},{"key":"11996_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jia2.25449\/full","volume":"23","author":"D Back","year":"2020","unstructured":"Back D, Marzolini C. The challenge of HIV treatment in an era of polypharmacy. J Intern AIDS Soc. 2020;23:1\u201312. https:\/\/doi.org\/10.1002\/jia2.25449\/full.","journal-title":"J Intern AIDS Soc"},{"key":"11996_CR11","doi-asserted-by":"publisher","unstructured":"Danjuma MI, Adegboye OA, Aboughalia A, Soliman N, Almishal R, Abdul H, et al. Prevalence and global trends of polypharmacy among people living with HIV: a systematic review and meta-analysis. Ther Adv Drug Saf. 2022;13. https:\/\/doi.org\/10.1177\/20420986221080795.","DOI":"10.1177\/20420986221080795"},{"key":"11996_CR12","doi-asserted-by":"publisher","unstructured":"Chang TI, Park H, Kim DW, Jeon EK, Rhee CM, Kalantar-Zadeh K et al. Polypharmacy, hospitalization, and mortality risk: a nationwide cohort study. Sci Rep 2020;10. https:\/\/doi.org\/10.1038\/s41598-020-75888-8.","DOI":"10.1038\/s41598-020-75888-8"},{"key":"11996_CR13","doi-asserted-by":"publisher","unstructured":"Zaninotto P, Huang YT, Di Gessa G, Abell J, Lassale C, Steptoe A. Polypharmacy is a risk factor for hospital admission due to a fall: evidence from the english longitudinal study of ageing. BMC Public Health. 2020;20. https:\/\/doi.org\/10.1186\/s12889-020-09920-x.","DOI":"10.1186\/s12889-020-09920-x"},{"key":"11996_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5770\/cgj.21.268","volume":"21","author":"Y Ming","year":"2018","unstructured":"Ming Y, Zecevic A. Medications & polypharmacy influence on recurrent fallers in community: a systematic review. Can Geriatr J. 2018;21:14\u201325. https:\/\/doi.org\/10.5770\/cgj.21.268.","journal-title":"Can Geriatr J"},{"key":"11996_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40264-015-0378-5","volume":"39","author":"CA Cadogan","year":"2016","unstructured":"Cadogan CA, Ryan C, Hughes CM. Appropriate polypharmacy and medicine safety: when many is not too many. Drug Saf. 2016;39:109\u201316. https:\/\/doi.org\/10.1007\/s40264-015-0378-5.","journal-title":"Drug Saf"},{"key":"11996_CR16","doi-asserted-by":"publisher","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr 2017;17. https:\/\/doi.org\/10.1186\/s12877-017-0621-2.","DOI":"10.1186\/s12877-017-0621-2"},{"key":"11996_CR17","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","volume":"63","author":"MJ Samuel","year":"2015","unstructured":"Samuel MJ. American geriatrics society 2015 updated beers\u2019 criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63:2227\u201346. https:\/\/doi.org\/10.1111\/jgs.13702.","journal-title":"J Am Geriatr Soc"},{"key":"11996_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/J.VHRI.2021.05.003","volume":"25","author":"SK Malakouti","year":"2021","unstructured":"Malakouti SK, Javan-Noughabi J, Yousefzadeh N, Rezapour A, Mortazavi SS, Jahangiri R, et al. A systematic review of potentially inappropriate medications use and related costs among the elderly. Value Health Reg Issues. 2021;25:172\u20139. https:\/\/doi.org\/10.1016\/J.VHRI.2021.05.003.","journal-title":"Value Health Reg Issues"},{"key":"11996_CR19","doi-asserted-by":"publisher","first-page":"E2145","DOI":"10.1093\/CID\/CIAA918","volume":"73","author":"E Deutschmann","year":"2021","unstructured":"Deutschmann E, Bucher HC, Jaeckel S, Gibbons S, McAllister K, Scherrer AU, et al. Prevalence of potential Drug-Drug interactions in patients of the Swiss HIV cohort study in the era of HIV integrase inhibitors. Clin Infect Dis. 2021;73:E2145\u201352. https:\/\/doi.org\/10.1093\/CID\/CIAA918.","journal-title":"Clin Infect Dis"},{"key":"11996_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/J.1468-1293.2008.00579.X","volume":"9","author":"MM Foisy","year":"2008","unstructured":"Foisy MM, Yakiwchuk EMK, Chiu I, Singh AE. Adrenal suppression and cushing\u2019s syndrome secondary to an interaction between Ritonavir and fluticasone: A review of the literature. HIV Med. 2008;9:389\u201396. https:\/\/doi.org\/10.1111\/J.1468-1293.2008.00579.X.","journal-title":"HIV Med"},{"key":"11996_CR21","doi-asserted-by":"publisher","unstructured":"Courlet P, Livio F, Guidi M, Cavassini M, Battegay M, Stoeckle M, et al. Polypharmacy, drug\u2013drug interactions, and inappropriate drugs: new challenges in the aging population with HIV. Open Forum Infect Dis. 2019;6. https:\/\/doi.org\/10.1093\/OFID\/OFZ531.","DOI":"10.1093\/OFID\/OFZ531"},{"key":"11996_CR22","doi-asserted-by":"publisher","unstructured":"V\u00e9lez-D\u00edaz-Pallar\u00e9s M, Delgado-Silveira E, Fern\u00e1ndez-Fradejas J, Montero-Llorente B, Palomar-Fern\u00e1ndez C, Montero-Errasqu\u00edn B, et al. Potentially inappropriate prescribing in older people living with HIV: a scoping review. J Acquir Immune Defic Syndr (1988). 2023;94(445\u201360). https:\/\/doi.org\/10.1097\/QAI.0000000000003298.","DOI":"10.1097\/QAI.0000000000003298"},{"key":"11996_CR23","doi-asserted-by":"publisher","first-page":"E2326910","DOI":"10.1001\/JAMANETWORKOPEN.2023.26910","volume":"6","author":"F Tian","year":"2023","unstructured":"Tian F, Chen Z, Zeng Y, Feng Q, Chen X. Prevalence of use of potentially inappropriate medications among older adults worldwide: a systematic review and meta-analysis. JAMA Netw Open. 2023;6:E2326910. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2023.26910.","journal-title":"JAMA Netw Open"},{"key":"11996_CR24","doi-asserted-by":"publisher","unstructured":"Mulugeta H, Sinclair PM, Wilson A. Prevalence of depression and its association with health-related quality of life in people with heart failure in low- and middle-income countries: a systematic review and meta-analysis. PLoS ONE. 2023;18. https:\/\/doi.org\/10.1371\/journal.pone.0283146.","DOI":"10.1371\/journal.pone.0283146"},{"key":"11996_CR25","doi-asserted-by":"publisher","unstructured":"Brkic J, Fialova D, Okuyan B, Kummer I, Sesto S, Capiau A, et al. Prevalence of potentially inappropriate prescribing in older adults in central and Eastern europe: a systematic review and synthesis without meta-analysis. Sci Rep. 2022;12. https:\/\/doi.org\/10.1038\/s41598-022-19860-8.","DOI":"10.1038\/s41598-022-19860-8"},{"key":"11996_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/13814788.2017.1288211","volume":"23","author":"H Storms","year":"2017","unstructured":"Storms H, Marquet K, Aertgeerts B, Claes N. Prevalence of inappropriate medication use in residential long-term care facilities for the elderly: A systematic review. Eur J Gen Pract. 2017;23:69\u201377. https:\/\/doi.org\/10.1080\/13814788.2017.1288211.","journal-title":"Eur J Gen Pract"},{"key":"11996_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00228-018-2446-0","volume":"74","author":"FR Motter","year":"2018","unstructured":"Motter FR, Fritzen JS, Hilmer SN, Paniz \u00c9V, Paniz VMV. Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria. Eur J Clin Pharmacol. 2018;74:679\u2013700. https:\/\/doi.org\/10.1007\/s00228-018-2446-0.","journal-title":"Eur J Clin Pharmacol"},{"key":"11996_CR28","doi-asserted-by":"publisher","unstructured":"Livio F, Marzolini C. Prescribing issues in older adults living with HIV: thinking beyond drug\u2013drug interactions with antiretroviral drugs. Ther Adv Drug Saf. 2019;10. https:\/\/doi.org\/10.1177\/2042098619880122.","DOI":"10.1177\/2042098619880122"},{"key":"11996_CR29","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/JGS.12695","volume":"62","author":"M Greene","year":"2014","unstructured":"Greene M, Steinman MA, McNicholl IR, Valcour V. Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection. J Am Geriatr Soc. 2014;62:447\u201353. https:\/\/doi.org\/10.1111\/JGS.12695.","journal-title":"J Am Geriatr Soc"},{"key":"11996_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.37201\/REQ\/070.2022","volume":"36","author":"P Garc\u00eda-Lloret","year":"2023","unstructured":"Garc\u00eda-Lloret P, Borrego-Izquierdo Y, Manzano-Garc\u00eda M, Cantillana-Su\u00e1rez MG, Guti\u00e9rrez-Pizarraya A, Morillo-Verdugo R. Potentially inappropriate medications according to Marc, STOPP and PRISCUS criteria in a cohort of elderly HIV + patients. The COMMPI project. Revista Esp De Quimioterapia. 2023;36:52\u20138. https:\/\/doi.org\/10.37201\/REQ\/070.2022.","journal-title":"Revista Esp De Quimioterapia"},{"key":"11996_CR31","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/HIV.13616","volume":"25","author":"J Fern\u00e1ndez-Fradejas","year":"2024","unstructured":"Fern\u00e1ndez-Fradejas J, Delgado-Silveira E, Gonz\u00e1lez-Burgos E, \u00c1lvarez-D\u00edaz AM, V\u00e9lez-D\u00edaz-Pallar\u00e9s M. Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV. HIV Med. 2024;25:587\u201399. https:\/\/doi.org\/10.1111\/HIV.13616.","journal-title":"HIV Med"},{"key":"11996_CR32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/J.EIMC.2020.11.014","volume":"40","author":"R D\u00edaz-Acedo","year":"2022","unstructured":"D\u00edaz-Acedo R, Soriano-Martinez M, Guti\u00e9rrez-Pizarraya A, Fernandez-Gonzalez-Caballos JA, Raya-Siles M, Morillo-Verdugo R. Prevalence of PIMDINAC criteria and associated factors in elderly HIV patients. Enferm Infecc Microbiol Clin. 2022;40:258\u201361. https:\/\/doi.org\/10.1016\/J.EIMC.2020.11.014.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"11996_CR33","doi-asserted-by":"publisher","unstructured":"Cantudo-Cuenca MD, Guti\u00e9rrez-Pizarraya A, Garc\u00eda-Lloret P, Gabella-Bazarot E, Morillo-Verdugo R. Prevalence of compliance with PIMDINAC criteria among elderly people living with HIV and in non-infected outpatients with other chronic diseases. Eur J Hosp Pharm 2022:ejhpharm-2022-003454. https:\/\/doi.org\/10.1136\/EJHPHARM-2022-003454.","DOI":"10.1136\/EJHPHARM-2022-003454"},{"key":"11996_CR34","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1111\/BCP.14513","volume":"87","author":"C Loste","year":"2021","unstructured":"Loste C, Molt\u00f3 J, P\u00e9rez-\u00c1lvarez N, Puig J, Echeverr\u00eda P, Bonjoch A, et al. Potential prescribing issues among older HIV-infected subjects in a mediterranean cohort: does the current prevalence give cause for concern? Br J Clin Pharmacol. 2021;87:1310\u20137. https:\/\/doi.org\/10.1111\/BCP.14513.","journal-title":"Br J Clin Pharmacol"},{"key":"11996_CR35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/HIV.12883","volume":"21","author":"B L\u00f3pez-Centeno","year":"2020","unstructured":"L\u00f3pez-Centeno B, Badenes-Olmedo C, Mataix-Sanjuan A, Bell\u00f3n JM, P\u00e9rez-Latorre L, L\u00f3pez JC, et al. Potentially inappropriate medications in older adults living with HIV. HIV Med. 2020;21:541\u20136. https:\/\/doi.org\/10.1111\/HIV.12883.","journal-title":"HIV Med"},{"key":"11996_CR36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.37201\/REQ\/087.2020","volume":"34","author":"EC Mac\u00edas","year":"2021","unstructured":"Mac\u00edas EC, Gim\u00e9nez RS, Verdugo RM. Prevalence of prescription of the top-10 drug classes to avoid in elderly people living with Hiv in a real practice cohort. Revista Esp De Quimioterapia. 2021;34:28\u201332. https:\/\/doi.org\/10.37201\/REQ\/087.2020.","journal-title":"Revista Esp De Quimioterapia"},{"key":"11996_CR37","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1002\/PHAR.2043","volume":"37","author":"IR McNicholl","year":"2017","unstructured":"McNicholl IR, Gandhi M, Hare CB, Greene M, Pierluissi E. A Pharmacist-led program to evaluate and reduce polypharmacy and potentially inappropriate prescribing in older HIV-positive patients. Pharmacotherapy. 2017;37:1498\u2013506. https:\/\/doi.org\/10.1002\/PHAR.2043.","journal-title":"Pharmacotherapy"},{"key":"11996_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/QAI.0000000000001653","volume":"78","author":"A Ranzani","year":"2018","unstructured":"Ranzani A, Oreni L, van den Agr\u00f2 M, Milazzo L, Giacomelli A, et al. Burden of exposure to potential interactions between antiretroviral and Non-Antiretroviral medications in a population of HIV-Positive patients aged 50 years or older. J Acquir Immune Defic Syndr. 2018;78:193\u2013201. https:\/\/doi.org\/10.1097\/QAI.0000000000001653.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"11996_CR39","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/S11096-021-01242-1","volume":"43","author":"JM Vinuesa-Hernando","year":"2021","unstructured":"Vinuesa-Hernando JM, Gimeno-Gracia M, Malo S, Sanjoaquin-Conde I, Crusells-Canales MJ, Letona-Carbajo S, et al. Potentially inappropriate prescriptions and therapeutic complexity in older HIV patients with comorbidities. Int J Clin Pharm. 2021;43:1245\u201350. https:\/\/doi.org\/10.1007\/S11096-021-01242-1.","journal-title":"Int J Clin Pharm"},{"key":"11996_CR40","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372. https:\/\/doi.org\/10.1136\/BMJ.N71.","DOI":"10.1136\/BMJ.N71"},{"key":"11996_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/QAI.0000000000001653","volume":"78","author":"A Ranzani","year":"2018","unstructured":"Ranzani A, Oreni L, Van Den Agr\u00f2 M, Milazzo L, Giacomelli A, et al. Burden of exposure to potential interactions between antiretroviral and non-antiretroviral medications in a population of HIV-positive patients aged 50 years or older. J Acquir Immune Defic Syndr. 2018;78:193\u2013201.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"11996_CR42","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/jac\/dkaa505","volume":"76","author":"F Livio","year":"2021","unstructured":"Livio F, Deutschmann E, Moffa G, Rrustemi F, Stader F, Elzi L, et al. Analysis of inappropriate prescribing in elderly patients of the Swiss HIV cohort study reveals gender inequity. J Antimicrob Chemother. 2021;76:758\u201364. https:\/\/doi.org\/10.1093\/jac\/dkaa505.","journal-title":"J Antimicrob Chemother"},{"key":"11996_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40267-021-00884-5","volume":"38","author":"M Naughton","year":"2022","unstructured":"Naughton M, Moriarty F, Bailey J, Bowen L, Redmond P, Molokhia CITATION, Naughton M. A systematic review of the prevalence, determinants, and impact of potentially inappropriate prescribing in middle-aged adults. Drugs Therapy Perspect. 2022;38:21\u201332.","journal-title":"Drugs Therapy Perspect"},{"key":"11996_CR44","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jval.2021.05","volume":"25","author":"S Kazem Malakouti","year":"2021","unstructured":"Kazem Malakouti S, Javan-Noughabi J, Yousefzadeh N, Rezapour A, Mortazavi S, Jahangiri R, et al. A systematic review of potentially inappropriate medications use and related costs among the elderly. Value Health Reg Issues. 2021;25:172\u20139. https:\/\/doi.org\/10.1016\/j.jval.2021.05.","journal-title":"Value Health Reg Issues"},{"key":"11996_CR45","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/ageing\/afaa057","volume":"49","author":"TM Liew","year":"2020","unstructured":"Liew TM, Lee CS, Goh SKL, Chang ZY. The prevalence and impact of potentially inappropriate prescribing among older persons in primary care settings: multilevel meta-analysis. Age Ageing. 2020;49:570\u20139. https:\/\/doi.org\/10.1093\/ageing\/afaa057.","journal-title":"Age Ageing"},{"key":"11996_CR46","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1111\/bcp.14870","volume":"87","author":"AB Mekonnen","year":"2021","unstructured":"Mekonnen AB, Redley B, de Courten B, Manias E. Potentially inappropriate prescribing and its associations with health-related and system-related outcomes in hospitalised older adults: a systematic review and meta-analysis. Br J Clin Pharmacol. 2021;87:4150\u201372. https:\/\/doi.org\/10.1111\/bcp.14870.","journal-title":"Br J Clin Pharmacol"},{"key":"11996_CR47","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1370\/afm.2373","volume":"17","author":"TM Liew","year":"2019","unstructured":"Liew TM, Lee CS, Goh KL, Chang ZY. Potentially inappropriate prescribing among older persons: a meta-analysis of observational studies. Ann Fam Med. 2019;17:257\u201366. https:\/\/doi.org\/10.1370\/afm.2373.","journal-title":"Ann Fam Med"},{"key":"11996_CR48","doi-asserted-by":"publisher","unstructured":"Gomes D, Herdeiro MT, Ribeiro-Vaz I, Ferreira PL, Roque F. Adverse drug reactions and potentially inappropriate medication in older patients: analysis of the Portuguese pharmacovigilance database. J Clin Med. 2022;11. https:\/\/doi.org\/10.3390\/jcm11082229.","DOI":"10.3390\/jcm11082229"},{"key":"11996_CR49","doi-asserted-by":"publisher","first-page":"eAO8024","DOI":"10.31744\/einstein_journal\/2022AO8024","volume":"20","author":"S Viana","year":"2022","unstructured":"Viana S, de SC, Souza NPDS, Aliberti MJR, Jacob-Filho W. Use of potentially inappropriate medications and adverse events in older outpatients with acute conditions. Einstein (Sao Paulo). 2022;20:eAO8024. https:\/\/doi.org\/10.31744\/einstein_journal\/2022AO8024.","journal-title":"Einstein (Sao Paulo)"},{"key":"11996_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-024-08817-4","author":"J Guillot","year":"2024","unstructured":"Guillot J, Justice AC, Gordon KS, Skanderson M, Pariente A, Bezin J, et al. Contribution of potentially inappropriate medications to polypharmacy-associated risk of mortality in middle-aged patients: a National cohort study. J Gen Intern Med. 2024. https:\/\/doi.org\/10.1007\/s11606-024-08817-4.","journal-title":"J Gen Intern Med"},{"key":"11996_CR51","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jamda.2016.11.025","volume":"18","author":"DC Muhlack","year":"2017","unstructured":"Muhlack DC, Hoppe LK, Weberpals J, Brenner H, Sch\u00f6ttker B. The association of potentially inappropriate medication at older age with cardiovascular events and overall mortality: a systematic review and meta-analysis of cohort studies. J Am Med Dir Assoc. 2017;18:211\u201320. https:\/\/doi.org\/10.1016\/j.jamda.2016.11.025.","journal-title":"J Am Med Dir Assoc"},{"key":"11996_CR52","doi-asserted-by":"publisher","unstructured":"Bhagavathula AS, Vidyasagar K, Chhabra M, Rashid M, Sharma R, Bandari DK, et al. Prevalence of polypharmacy, hyperpolypharmacy and potentially inappropriate medication use in older adults in India: a systematic review and meta-analysis. Front Pharmacol. 2021;12. https:\/\/doi.org\/10.3389\/fphar.2021.685518.","DOI":"10.3389\/fphar.2021.685518"},{"key":"11996_CR53","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cgpj.2024.03.006","volume":"1","author":"Y Luo","year":"2024","unstructured":"Luo Y, Kong L, Lv Q, Yao H. Prevalence and associated factors of potentially inappropriate medication in community-dwelling older adults in china: A meta-analysis. Chin Gen Pract J. 2024;1:54\u201361. https:\/\/doi.org\/10.1016\/j.cgpj.2024.03.006.","journal-title":"Chin Gen Pract J"},{"key":"11996_CR54","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/QAD.0000000000001756","volume":"32","author":"AC Justice","year":"2018","unstructured":"Justice AC, Gordon KS, Skanderson M, Edelman EJ, Akg\u00fcn KM, Gibert CL, et al. Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals. AIDS. 2018;32:739\u201349. https:\/\/doi.org\/10.1097\/QAD.0000000000001756.","journal-title":"AIDS"},{"key":"11996_CR55","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.jiph.2020.08.009","volume":"13","author":"FM Farahat","year":"2020","unstructured":"Farahat FM, Alghamdi YS, Farahat AF, Alqurashi AA, Alburayk AK, Alabbasi AA, et al. The prevalence of comorbidities among adult people diagnosed with HIV infection in a tertiary care hospital in Western Saudi Arabia. J Infect Public Health. 2020;13:1699\u2013704. https:\/\/doi.org\/10.1016\/j.jiph.2020.08.009.","journal-title":"J Infect Public Health"},{"key":"11996_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/jama.2019.19775","volume":"323","author":"AM Lerner","year":"2020","unstructured":"Lerner AM, Eisinger RW, Fauci AS. Comorbidities in persons with HIV: the lingering challenge. JAMA - J Am Med Association. 2020;323:19\u201320. https:\/\/doi.org\/10.1001\/jama.2019.19775.","journal-title":"JAMA - J Am Med Association"},{"key":"11996_CR57","doi-asserted-by":"publisher","unstructured":"Maggi P, Di Biagio A, Rusconi S, Cicalini S, D\u2019Abbraccio M, d\u2019Ettorre G, et al. Cardiovascular risk and dyslipidemia among persons living with HIV: a review. BMC Infect Dis. 2017;17. https:\/\/doi.org\/10.1186\/s12879-017-2626-z.","DOI":"10.1186\/s12879-017-2626-z"},{"key":"11996_CR58","doi-asserted-by":"publisher","unstructured":"Blanco C, Han B, Jones CM, Johnson K, Compton WM. Prevalence and correlates of benzodiazepine use, misuse, and use disorders among adults in the United States. J Clin Psychiatry. 2018;79. https:\/\/doi.org\/10.4088\/JCP.18m12174.","DOI":"10.4088\/JCP.18m12174"},{"key":"11996_CR59","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/QAI","volume":"82","author":"R Saloner","year":"2019","unstructured":"Saloner R, Grelotti DJ, Tyree G, Sundermann EE, Ma Q, Letendre S, et al. Benzodiazepine use is associated with an increased risk of neurocognitive impairment in people living with HIV HHS public access. J Acquir Immune Defic Syndr. 2019;82:475\u201382. https:\/\/doi.org\/10.1097\/QAI.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"11996_CR60","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/J.SAPHARM.2023.10.013","volume":"20","author":"MM Abubakar","year":"2024","unstructured":"Abubakar MM, Loosli K, Isah A, Usman M, Fatokun O, Amidu I, et al. Assessing the impact of COVID-19 on prescription patterns and antibiotic use: insights from three military health facilities. Res Social Adm Pharm. 2024;20:157\u201362. https:\/\/doi.org\/10.1016\/J.SAPHARM.2023.10.013.","journal-title":"Res Social Adm Pharm"},{"key":"11996_CR61","doi-asserted-by":"publisher","unstructured":"Nandi A, Pecetta S, Bloom DE. Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020\u20132022. EClinicalMedicine 2023;57. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101848.","DOI":"10.1016\/j.eclinm.2023.101848"},{"key":"11996_CR62","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","volume":"27","author":"BJ Langford","year":"2021","unstructured":"Langford BJ, So M, Raybardhan S, Leung V, Soucy JPR, Westwood D, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021;27:520\u201331. https:\/\/doi.org\/10.1016\/j.cmi.2020.12.018.","journal-title":"Clin Microbiol Infect"},{"key":"11996_CR63","doi-asserted-by":"publisher","unstructured":"Le-Dang MA, Nguyen-Thi HY, Dinh LP, Le Ngoc D, Le NDT, Thu HP, et al. Impact of COVID-19 on patterns of drug utilization: a case study at national hospital. PLoS ONE. 2024;19. https:\/\/doi.org\/10.1371\/journal.pone.0297187.","DOI":"10.1371\/journal.pone.0297187"},{"key":"11996_CR64","doi-asserted-by":"publisher","unstructured":"Mooses K, Vesilind K, Oja M, Tamm S, Haug M, Kalda R, et al. The use of prescription drugs and health care services during the 6-month post-COVID-19 period. Sci Rep. 2023;13. https:\/\/doi.org\/10.1038\/s41598-023-38691-9.","DOI":"10.1038\/s41598-023-38691-9"},{"key":"11996_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpubh.2022.1041695","volume":"10","author":"G Kazemioula","year":"2022","unstructured":"Kazemioula G, Golestani S, Seyed MAA, Taheri F, Gheshlagh RG, Lotfalizadeh MH. Prevalence of self-medication during COVID-19 pandemic: a systematic review and meta-analysis. Front Public Health. 2022;10:1\u201316.","journal-title":"Front Public Health"},{"key":"11996_CR66","doi-asserted-by":"publisher","unstructured":"Zheng Y, Liu J, Tang PK, Hu H, Ung COL. A systematic review of self-medication practice during the COVID-19 pandemic: implications for pharmacy practice in supporting public health measures. Front Public Health. 2023;11. https:\/\/doi.org\/10.3389\/fpubh.2023.1184882.","DOI":"10.3389\/fpubh.2023.1184882"},{"key":"11996_CR67","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.2147\/TCRM.S170475","volume":"14","author":"R Abdulah","year":"2018","unstructured":"Abdulah R, Insani WN, Destiani DP, Rohmaniasari N, Mohenathas ND, Barliana MI. Polypharmacy leads to increased prevalence of potentially inappropriate medication in the Indonesian geriatric population visiting primary care facilities. Ther Clin Risk Manag. 2018;14:1591\u20137. https:\/\/doi.org\/10.2147\/TCRM.S170475.","journal-title":"Ther Clin Risk Manag"},{"key":"11996_CR68","doi-asserted-by":"publisher","unstructured":"Akande-Sholabi W, Adebusoye LA, Olowookere OO. Potentially inappropriate medication use among older patients attending a geriatric centre in south-west Nigeria. Pharm Pract (Granada). 2018;16. https:\/\/doi.org\/10.18549\/PHARMPRACT.2018.03.1235.","DOI":"10.18549\/PHARMPRACT.2018.03.1235"},{"key":"11996_CR69","doi-asserted-by":"publisher","unstructured":"Bhagavathula AS, Vidyasagar K, Chhabra M, Rashid M, Sharma R, Bandari DK, et al. Prevalence of polypharmacy, hyperpolypharmacy and potentially inappropriate medication use in older adults in India: a systematic review and meta-analysis. Front Pharmacol. 2021;12. https:\/\/doi.org\/10.3389\/FPHAR.2021.685518\/FULL.","DOI":"10.3389\/FPHAR.2021.685518\/FULL"},{"key":"11996_CR70","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2147\/TCRM.S40120","volume":"9","author":"JO Fadare","year":"2013","unstructured":"Fadare JO, Agboola SM, Opeke OA, Alabi RA. Prescription pattern and prevalence of potentially inappropriate medications among elderly patients in a Nigerian rural tertiary hospital. Ther Clin Risk Manag. 2013;9:115\u201320. https:\/\/doi.org\/10.2147\/TCRM.S40120.","journal-title":"Ther Clin Risk Manag"},{"key":"11996_CR71","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cgpj.2024.03.006","volume":"1","author":"Y LUO","year":"2024","unstructured":"LUO Y, KONG L, LV Q. Prevalence and associated factors of potentially inappropriate medication in community-dwelling older adults in china: A meta-analysis. Chin Gen Pract J. 2024;1:54\u201361. https:\/\/doi.org\/10.1016\/j.cgpj.2024.03.006.","journal-title":"Chin Gen Pract J"},{"key":"11996_CR72","doi-asserted-by":"publisher","unstructured":"Nigussie S, Demeke F. Potentially inappropriate medications use and associated factors among older patients on follow-up at the chronic care clinic of Hiwot Fana comprehensive specialized hospital in Eastern Ethiopia. Curr Ther Res Clin Exp. 2024;100. https:\/\/doi.org\/10.1016\/J.CURTHERES.2023.100730.","DOI":"10.1016\/J.CURTHERES.2023.100730"},{"key":"11996_CR73","doi-asserted-by":"publisher","first-page":"e2832","DOI":"10.1590\/1518-8345.1193.2832","volume":"24","author":"WM Santos","year":"2016","unstructured":"Santos WM, Dos, Secoli SR, de Padoin SM. Potential drug interactions in patients given antiretroviral therapy. Rev Lat Am Enfermagem. 2016;24:e2832. https:\/\/doi.org\/10.1590\/1518-8345.1193.2832.","journal-title":"Rev Lat Am Enfermagem"},{"key":"11996_CR74","doi-asserted-by":"publisher","unstructured":"Rodrigues DA, Pl\u00e1cido AI, Mateos-Campos R, Figueiras A, Herdeiro MT, Roque F. Effectiveness of interventions to reduce potentially inappropriate medication in older patients: a systematic review. Front Pharmacol. 2022;12. https:\/\/doi.org\/10.3389\/FPHAR.2021.777655.","DOI":"10.3389\/FPHAR.2021.777655"},{"key":"11996_CR75","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/JPHSR\/RMAB038","volume":"12","author":"D Kroon","year":"2021","unstructured":"Kroon D, Steutel NF, Vermeulen H, Tabbers MM, Benninga MA, Langendam MW, et al. Effectiveness of interventions aiming to reduce inappropriate drug prescribing: an overview of interventions. J Pharm Health Serv Res. 2021;12:423\u201333. https:\/\/doi.org\/10.1093\/JPHSR\/RMAB038.","journal-title":"J Pharm Health Serv Res"},{"key":"11996_CR76","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/S11606-020-06089-2","volume":"35","author":"HE Bloomfield","year":"2020","unstructured":"Bloomfield HE, Greer N, Linsky AM, Bolduc J, Naidl T, Vardeny O, et al. Deprescribing for community-dwelling older adults: a systematic review and meta-analysis. J Gen Intern Med. 2020;35:3323\u201332. https:\/\/doi.org\/10.1007\/S11606-020-06089-2.","journal-title":"J Gen Intern Med"},{"key":"11996_CR77","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/PHARMACY13040109","volume":"13","author":"F McGrory","year":"2025","unstructured":"McGrory F, Elnaem MH. Pharmacist-Led interventions for polypharmacy management in older adults: a systematic review of strategies and outcomes in the United Kingdom and the Republic of Ireland. Pharm (Basel). 2025;13:109. https:\/\/doi.org\/10.3390\/PHARMACY13040109.","journal-title":"Pharm (Basel)"},{"key":"11996_CR78","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMRA032424","volume":"352","author":"GR Wilkinson","year":"2005","unstructured":"Wilkinson GR. Drug metabolism and variability among patients in drug response. N Engl J Med. 2005;352:2211\u201321. ;PAGEGROUP:STRING:PUBLICATION. https:\/\/doi.org\/10.1056\/NEJMRA032424.","journal-title":"N Engl J Med"},{"key":"11996_CR79","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1345\/APH.1P576","volume":"45","author":"N Patel","year":"2011","unstructured":"Patel N, Abdelsayed S, Veve M, Miller CD. Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens. Ann Pharmacother. 2011;45:317\u201324. https:\/\/doi.org\/10.1345\/APH.1P576.","journal-title":"Ann Pharmacother"},{"key":"11996_CR80","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/0956462416661437","volume":"28","author":"K Yoganathan","year":"2017","unstructured":"Yoganathan K, Roberts B, Heatley MK. Life-threatening Digoxin toxicity due to drug\u2013drug interactions in an HIV-positive man. Int J STD AIDS. 2017;28:297\u2013301. https:\/\/doi.org\/10.1177\/0956462416661437.","journal-title":"Int J STD AIDS"},{"key":"11996_CR81","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/JINF.2001.0928","volume":"44","author":"P Clevenbergh","year":"2002","unstructured":"Clevenbergh P, Corcostegui M, G\u00e9rard D, Hieronimus S, Mondain V, Chichmanian RM, et al. Iatrogenic cushing\u2019s syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose Ritonavir enhanced PI containing regimen. J Infect. 2002;44:194\u20135. https:\/\/doi.org\/10.1053\/JINF.2001.0928.","journal-title":"J Infect"},{"key":"11996_CR82","doi-asserted-by":"publisher","unstructured":"Boyd SD, Hadigan C, McManus M, Chairez C, Nieman LK, Pau AK et al. Influence of low-dose ritonavir with and without darunavir on the pharmacokinetics and pharmacodynamics of inhaled beclomethasone. J Acquir Immune Defic Syndr (1988) 2013;63:355\u201361. https:\/\/doi.org\/10.1097\/QAI.0B013E31829260D6.","DOI":"10.1097\/QAI.0B013E31829260D6"},{"key":"11996_CR83","doi-asserted-by":"publisher","unstructured":"Persaud N, Workentin A, Rizvi A, Pierson T, Bortolussi-Courval \u00c9, Liu K, et al. Interventions to address potentially inappropriate prescribing for older primary care patients a systematic review and meta-analysis. JAMA Netw Open. 2025;8. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2025.17965.","DOI":"10.1001\/JAMANETWORKOPEN.2025.17965"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11996-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11996-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11996-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:46:48Z","timestamp":1763038008000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11996-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11996"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11996-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethics review was required as the study involved analysis of published studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1571"}}